Tech Company Financing Transactions
Kincell Bio Funding Round
Kincell Bio closed a $36 million Series A venture capital round on 7/26/2023. Investors included Kineticos Ventures.
Transaction Overview
Company Name
Announced On
7/26/2023
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series A
Investors
Kineticos Ventures (Lead Investor)
Proceeds Purpose
to Make Cell Therapy Development and Manufacturing Accessible for Early-Stage Innovators
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1622 North West 55th Place
Gainesville, FL 32653
USA
Gainesville, FL 32653
USA
Phone
Undisclosed
Website
Email Address
Overview
Kincell Bio leverages extensive scientific expertise and industry knowledge to partner with cell therapy innovators. Our core values of transparency, accountability, and accuracy are at the heart of what makes us a trusted partner for process and analytical development, CMC support, and high-quality clinical cell therapy manufacturing services.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Shailesh Maingi
Chief Executive Officer
Bruce Thompson
Browse more venture capital transactions:
Prev: 7/26/2023: Exponential Exchange venture capital transaction
Next: 7/26/2023: Dioxycle venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs